1. Home
  2. ANIX vs FGBI Comparison

ANIX vs FGBI Comparison

Compare ANIX & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.74

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

HOLD

Current Price

$8.67

Market Cap

134.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
FGBI
Founded
1982
1934
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
134.1M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
ANIX
FGBI
Price
$2.74
$8.67
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
332.0K
14.0K
Earning Date
05-27-2026
04-27-2026
Dividend Yield
N/A
0.44%
EPS Growth
12.82
N/A
EPS
N/A
0.31
Revenue
$210,000.00
N/A
Revenue This Year
N/A
$567.70
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$28.00
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$4.31
52 Week High
$5.46
$11.02

Technical Indicators

Market Signals
Indicator
ANIX
FGBI
Relative Strength Index (RSI) 34.69 50.58
Support Level $2.37 $8.24
Resistance Level $3.09 $8.86
Average True Range (ATR) 0.19 0.27
MACD -0.05 0.08
Stochastic Oscillator 15.89 74.76

Price Performance

Historical Comparison
ANIX
FGBI

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana through several banking facilities. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and, to a lesser extent, consumer and multifamily loans. The company is engaged in a single line of business as a financial institution, which provides a full range of banking, financial, and trust services to state, county, and local government entities, individuals, and small and commercial businesses.

Share on Social Networks: